In March 2022, the U.S. Food and Drug Administration released a Letter to Health Care Personnel alerting personnel that prefilled Sodium chloride 0.9% injection (NS) syringes are in shortage due to increased demand, supply chain challenges, and manufacturer discontinuation. NS syringes are used for flushing venous access devices (VADs).
Prefilled NS syringe shortages impact patient care, particularly for home infusion patients, and NHIA is continually addressing the ongoing shortage by working with manufacturers and suppliers, other professional health care organizations, and clinicians. Through these efforts, the association is staying up to date on the status of the shortages, collaborating to resolve them, and providing resources for managing the limited supply.
NHIA has compiled product shortage recommendations to help clinicians manage patient care and conserve prefilled NS syringe supplies during this time when they may not be readily available.
Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2024. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
NHIA submitted comments on a CMS PFS proposed rule (CMS-1784-P) that would affect Medicare classification and coverage of self-administered drugs, certain biologics and coding and billing requirements related to the use of single dose containers and drug waste.
